Oncoresponse

Developer of immunotherapies for the treatment of cancer

placeSeattle, Washington, United States calendar_todayFounded 2015 groups33 employees language oncoresponse.com

Registered entities

Investor mix

20 investors on record; lead investors include Baxalta, RiverVest Venture Partners, Qatar Investment Authority, Rice University.

Investor typeCountShare
Venture capital945%
Private equity15%
Bank & private debt15%
Other / undisclosed945%
Coming soon